271 Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
https://www.nejm.org/doi/full/10.1056/NEJMoa1912388?query=featured_home
270 Restraining cardiotoxic T cells through manipulation of the microbiome transforms inflammatory cardiomyopathy into a targetable disease.
https://science.sciencemag.org/content/366/6467/881
269 Platelet-induced myeloid Socs3 expression in humans and mice contributes to unresolved atherosclerosis inflammation and sustained plaque growth.
https://stm.sciencemag.org/content/11/517/eaax0481
268 Targeting cardiac fibrosis with engineered T cells.
https://www.nature.com/articles/s41586-019-1546-z
267 Cell therapy in a rat model of heart attack is enhanced by stem-cell-derived epicardium.
https://www.nature.com/articles/s41587-019-0197-9
266 Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
https://www.nejm.org/doi/full/10.1056/NEJMoa1803180?query=featured_home
265 Dynamic secretome of bone marrow-derived stromal cells reveals a cardioprotective biochemical cocktail.
https://www.pnas.org/content/116/28/14374
264 The Translational Landscape of the Human Heart.
https://www.cell.com/cell/fulltext/S0092-8674(19)30508-2
263 Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
https://www.nejm.org/doi/full/10.1056/NEJMoa1803377
262 A heart anomaly in children can be caused by a combination of rare heterozygous mutations inherited from asymptomatic parents.
https://science.sciencemag.org/content/364/6443/865
|
